| #1 |
Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation |
HCRTR1/HCRTR2 |
0.697 |
$0.70 |
| **Overview**
This therapeutic hypothesis proposes leveraging orexin (hypocretin) receptor modulation to enhance glymphatic system function through strengthening circadian rhythms in Alzheimer's disea... |
| #2 |
Matrix Stiffness Normalization via Targeted Lysyl Oxidase Inhibition |
LOX/LOXL1-4 |
0.639 |
$0.64 |
| Selective inhibition of lysyl oxidase (LOX) enzymes could reduce pathological collagen cross-linking in perivascular spaces, restoring tissue compliance necessary for effective CSF-ISF exchange.... |
| #3 |
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulation |
SDC1 |
0.631 |
$0.63 |
| Targeted upregulation of syndecan-1 through small molecule enhancers or gene therapy could restore the endothelial glycocalyx layer, improving the hydrodynamic properties essential for paravascular CS... |
| #4 |
Astroglial Gap Junction Coordination via Connexin-43 Phosphorylation Modulation |
GJA1 |
0.588 |
$0.59 |
| Selective inhibition of connexin-43 phosphorylation at serine residues could maintain open gap junction channels between astrocytes, facilitating coordinated calcium waves that drive perivascular pump... |
| #5 |
Pericyte Contractility Reset via Selective PDGFR-β Agonism |
PDGFRB |
0.532 |
$0.53 |
| Designer PDGFR-β agonists with biased signaling toward contractility pathways could restore pericyte tone and perivascular space dimensions while avoiding proliferative signals.... |
| #6 |
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation |
KCNK2 |
0.517 |
$0.52 |
| Chronic activation of TREK-1 potassium channels in astrocytic endfeet could restore AQP4 polarization by modulating membrane lipid composition and cytoskeletal organization.... |
| #7 |
Osmotic Gradient Restoration via Selective AQP1 Enhancement in Choroid Plexus |
AQP1 |
0.490 |
$0.49 |
| Targeted upregulation of AQP1 specifically in choroid plexus epithelium could restore proper CSF production and osmotic driving forces for glymphatic flow.... |